
6.48BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US19240Q2012
CUSIP
19240Q201
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
3.18
Dividend Share
-
Dividend Yield
-
Earnings Share
-2.24
Wall Street Target Price
54.25
EPS Estimate Current Year
-2.26
EPS Estimate Next Year
-0.96
EPS Estimate Current Quarter
-0.5402
EPS Estimate Next Quarter
-0.5439
Most Recent Quarter
-
Revenue TTM
0
Gross Profit TTM
-121,627,000
EBITDA
-359,487,008
Profit Margin
0.00%
Return On Assets TTM
-38.13%
Return On Equity TTM
-85.72%
Revenue Per Share TTM
0
Qtly Revenue Growth YOY
-100.00%
Diluted Eps TTM
-2.24
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
861.1519
Price Book MRQ
11.9463
Enterprise Value Revenue
929
Enterprise Value EBITDA
-3
184.89
3.18%21.76
1.54%136.00
0.40%860.55
0.25%85.50
0.00%865.00
-7.52%267.53
-5.47%273.25
-2.27%676.89
-0.31%485.88
-0.05%